Picture of Semnur Pharmaceuticals logo

SMNR Semnur Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapValue Trap

Brief: Denali Capital Shareholders Approve Extension For Business Combination Deadline

April 14 (Reuters) - Denali Capital Acquisition Corp DECA.O:

DENALI CAPITAL ACQUISITION CORP. ANNOUNCES SHAREHOLDER APPROVAL OF EXTENSION OF DEADLINE TO COMPLETE BUSINESS COMBINATION

DENALI CAPITAL ACQUISITION CORP - SHAREHOLDERS APPROVE EXTENSION TO DECEMBER 11, 2025

Source text: ID:nGNXbjTK3f

Further company coverage: DECA.O

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Semnur Pharmaceuticals

See all news